Sort:
Open Access Basic Research Issue
Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
International Journal of Ophthalmology 2023, 16(11): 1734-1745
Published: 18 November 2023
Abstract PDF (3.8 MB) Collect
Downloads:49
AIM

To evaluate the relationship between gene polymorphism (BclI, ER22/23EK, N363S) and the occurrence, progression and sensitivity to glucocorticoid of lacrimal gland benign lymphoepithelial lesion (LGBLEL).

METHODS

Clinical peripheral blood samples of 52 LGBLEL patients and 10 normal volunteers were collected for DNA extraction and polymerase chain reaction sequencing to analyze single nucleotide polymorphism (SNP) genotypes. The lacrimal tissues of LGBLEL were surgically removed and made into paraffin sections for subsequent hematoxylin-eosin (HE) and Masson staining analysis. The duration of disease and hormone use of LGBLEL patients from diagnosis to surgery were also analyzed. The Meta-analysis follows PRISMA guidelines to conducted a systematic review of human studies investigating the relationship between the NR3C1 BclI polymorphism and glucocorticoids (GCs) sensitivity.

RESULTS

There was no association between ER22/23EK or N363S and the occurrence of LGBLEL or GCs sensitivity (P>0.05); BclI GC genotype was closely related to GCs resistance (P=0.03) as is the minor allele C (P=0.0017). The HE staining and Masson staining showed that the GC genotype of BclI remarkably slowed down the disease progression and reduced fibrosis (P<0.05), especially for GCs-dependent patients (P<0.0001). Meta-analysis showed that BclI was not significantly associated with GCs responsiveness.

CONCLUSION

The LGBLEL patients who carry the NR3C1 BclI allele C may be more sensitive to GCs and associated with lower fibrosis and slower disease progression. The results may guide the clinical treatment strategy for the LGBLEL patients.

Open Access Research Article Issue
Hydrogen Inhalation Ameliorates Oxidative Stress and Glucose Metabolism Disorder in the Brain of Hindlimb Unloading Rats
Space: Science & Technology 2023, 3: 0027
Published: 29 March 2023
Abstract PDF (3.9 MB) Collect
Downloads:7

Many studies have shown that spaceflight causes oxidative stress and induces brain disorder in astronauts, but the counter measurements are lacking. Increasing evidence demonstrated that hydrogen can act as a therapeutic antioxidant. In this study, rats were treated with or without about 5% hydrogen under hindlimb unloading or normal conditions for 28 d. We assessed rat’s brain function by open-field test, step-down passive avoidance test, the neurotransmitter’s level detected by liquid chromatography with tandem mass spectrometry, and Nissl and hematoxylin–eosin staining analysis. We also assessed the oxidative damage by changes of malondialdehyde level, the ratio of reduced glutathione to oxidized glutathione, and superoxide dismutase and catalase activity. Glucose metabolism disorder was disclosed through glucose metabolomic analysis. The underlying mechanism of the effects of hydrogen was analyzed by mRNA sequencing and detecting mRNA and protein levels. Our data showed that hindlimb unloading caused oxidative damage and glucose metabolism disorder in brain tissues and decreased brain function in rats. Hydrogen inhalation reduced oxidative damage, ameliorated glucose metabolism disorder, and alleviated the dysfunction of rat brain function. Peroxisome-proliferator-activated receptor gamma coactivator 1α and brain-derived neurotrophic factor, the key regulators of glucose metabolism and brain function, were obviously affected. This research confirms the protective effect of hydrogen inhalation on declining brain function under hindlimb unloading conditions and discloses the underlying mechanism, which provides a potential strategy for astronauts’ health.

Total 2